Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases

European Journal of Cancer

Volumn 49, Issue 11, 2013, Pages 2486-2493

  Van Kessel, C S ^a   Samim, M ^a   Koopman, M ^a   Van Den Bosch, M A A J ^a   Borel Rinkes, I H M ^a   Punt, C J A ^b   Van Hillegersberg, R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chemotherapy; Colorectal liver; Heterogeneity; metastases; RECIST criteria; Response assessment; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; IRINOTECAN; LACTATE DEHYDROGENASE; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SYSTEMIC THERAPY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84879323832     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.03.027     Document Type: Article

References (24)

1. M.M. Center, A. Jemal, R.A. Smith, and E. Ward Worldwide variations in colorectal cancer CA Cancer J Clin 59 2009 366 378
2. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
3. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
4. S. Sharma, C. Camci, and N. Jabbour Management of hepatic metastasis from colorectal cancers: an update J Hepatobiliary Pancreat Surg 15 2008 570 580
5. J. Tol, M. Koopman, and A. Cats Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer N Engl J Med 360 2009 563 572
6. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
7. A.R. Padhani, and L. Ollivier The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists Br J Radiol 74 2001 983 986
8. B. Baisse, H. Bouzourene, E.P. Saraga, F.T. Bosman, and J. Benhattar Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma Int J Cancer 93 2001 346 352
9. H. Blaker, M. Graf, R.J. Rieker, and H.F. Otto Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases J Pathol 188 1999 258 262
10. N. Goasguen, C. de Chaisemartin, and A. Brouquet Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents Int J Cancer 127 2010 1028 1037
11. L. Losi, B. Baisse, H. Bouzourene, and J. Benhattar Evolution of intratumoral genetic heterogeneity during colorectal cancer progression Carcinogenesis 26 2005 916 922
12. L. Thorstensen, H. Qvist, J.M. Nesland, K.E. Giercksky, and R.A. Lothe Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients Int J Cancer 69 1996 452 456
13. M. Koopman, N.F. Antonini, and J. Douma Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study Ann Oncol 17 2006 1523 1528
14. M. Koopman, N.F. Antonini, and J. Douma Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Lancet 370 2007 135 142
15. J. Tol, M. Koopman, and C.J. Rodenburg A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity Ann Oncol 19 2008 734 738
16. L. Polissar, and P. Diehr Regression analysis in health services research: the use of dummy variables Med Care 20 1982 959 966
17. B. Liu, N.C. Nicolaides, and S. Markowitz Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability Nat Genet 9 1995 48 55
18. F. Al-Mulla, J.J. Going, E.T. Sowden, A. Winter, I.R. Pickford, and G.D. Birnie Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality J Pathol 185 1998 130 138
19. W. Giaretti, R. Monaco, N. Pujic, A. Rapallo, S. Nigro, and E. Geido Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy Am J Pathol 149 1996 237 245
20. M.R. Giovagnoli, E. Giarnieri, G. Midiri, A. Tesoriere, S. Ferraro, and A. Vecchione Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis Anticancer Res 19 1999 4577 4580
21. J.S. Zhang, S. Caplin, F.T. Bosman, and J. Benhattar Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymph-node metastases Int J Cancer 70 1997 674 678
22. J.S. Vermaat, I.J. Nijman, and M.J. Koudijs Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment Clin Cancer Res 18 2012 688 699
23. L.H. Schwartz, M. Mazumdar, W. Brown, A. Smith, and D.M. Panicek Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement Clin Cancer Res 9 2003 4318 4323
24. M. Buyse, P. Thirion, R.W. Carlson, T. Burzykowski, G. Molenberghs, and P. Piedbois Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer Lancet 356 2000 373 378